samarium Sm 153-DOTMP
Term · Oncology and biomedicine · MLC-T-ONC-016633
A radioconjugate composed of the phosphonic acid chelator DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylenephosphonic acid) conjugated to the beta- and gamma-emitting radioisotope samarium Sm 153, with potential antineoplastic activity. Upon administration of samarium Sm 153-DOTMP, the DOTMP moiety targets and binds to growing bone, thereby selectively delivering samarium Sm 153-mediated cytotoxic radiation to bone tumor and metastases, which may help destroy bone metastases and mitigate pain from bone metastases.
| Identifier | MLC-T-ONC-016633 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 153Sm-DOTMP; Sm-153-DOTMP; 153 Sm-DOTMP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016633",
"term": "samarium Sm 153-DOTMP",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of the phosphonic acid chelator DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylenephosphonic acid) conjugated to the beta- and gamma-emitting radioisotope samarium Sm 153, with potential antineoplastic activity. Upon administration of samarium Sm 153-DOTMP, the DOTMP moiety targets and binds to growing bone, thereby selectively delivering samarium Sm 153-mediated cytotoxic radiation to bone tumor and metastases, which may help destroy bone metastases and mitigate pain from bone metastases.",
"synonyms": [
"153Sm-DOTMP",
"Sm-153-DOTMP",
"153 Sm-DOTMP"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/samarium-sm-153-dotmp/"
}
Record 14,666 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.